Resistance to thyroid hormone (RTH), a human syndrome, is characterized by high thyroid hormone (TH) and thyroid-stimulating hormone (TSH) levels. Mice with mutations in the thyroid hormone receptor beta (TRβ) gene that cannot bind steroid receptor coactivator 1 (SRC-1) and
Src-1−/− mice both have phenotypes similar to that of RTH. Conversely, mice expressing a mutant nuclear corepressor 1 (
Ncor1) allele that cannot interact with TRβ, termed NCoRΔID, have low TH levels and normal TSH. We hypothesized that
Src-1−/− mice have RTH due to unopposed corepressor action. To test this, we crossed NCoRΔID and
Src-1−/− mice to create mice deficient for coregulator action in all cell types. Remarkably, NCoR
ΔID/ΔID
Src-1−/− mice have normal TH and TSH levels and are triiodothryonine (T
3) sensitive at the level of the pituitary. Although absence of SRC-1 prevented T
3 activation of key hepatic gene targets, NCoR
ΔID/ΔID
Src-1−/− mice reacquired hepatic T
3 sensitivity. Using
in vivo chromatin immunoprecipitation assays (ChIP) for the related coactivator SRC-2, we found enhanced SRC-2 recruitment to TR-binding regions of genes in NCoR
ΔID/ΔID
Src-1−/− mice, suggesting that SRC-2 is responsible for T
3 sensitivity in the absence of NCoR1 and SRC-1. Thus, T
3 targets require a critical balance between NCoR1 and SRC-1. Furthermore, replacement of NCoR1 with NCoRΔID corrects RTH in
Src-1−/− mice through increased SRC-2 recruitment to T
3 target genes.
相似文献